These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 10472348)

  • 21. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
    Palmedo H; Bender H; Grünwald F; Mallmann P; Zamora P; Krebs D; Biersack HJ
    Eur J Nucl Med; 1997 Sep; 24(9):1138-45. PubMed ID: 9283107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis.
    Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
    Breast Cancer Res Treat; 2004 Jan; 83(2):129-38. PubMed ID: 14997043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer.
    Kim SJ; Kim IJ; Bae YT; Kim YK; Kim DS
    Eur J Radiol; 2005 Feb; 53(2):192-8. PubMed ID: 15664282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
    Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
    Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
    Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
    J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of drug resistance protein related to Tc-99m MIBI breast imaging.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(3B):2021-5. PubMed ID: 10928145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Breast carcinoma and the axillary lymph node status: the use of 99mTc-sestamibi scintimammography for the diagnosis and preoperative staging. Preliminary results].
    Cistaro A; Bonazzi G; Bellò M; Bessone M; Tetti M; Villata E; Coluccia C; Bisi G; Massaioli N
    Minerva Chir; 1997 Oct; 52(10):1177-82. PubMed ID: 9471568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
    Nishiyama Y; Yamamoto Y; Ono Y; Irie A; Yamauchi A; Satoh K; Ohkawa M
    Eur J Nucl Med; 2001 Apr; 28(4):522-8. PubMed ID: 11357504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 99Tcm-MIBI scintimammography in 300 consecutive patients: factors that may affect accuracy.
    Tofani A; Sciuto R; Semprebene A; Festa A; Pasqualoni R; Giunta S; Mottolese M; Benevolo M; Botti C; Maini CL
    Nucl Med Commun; 1999 Dec; 20(12):1113-21. PubMed ID: 10664992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
    Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D
    Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
    Papantoniou V; Tsiouris S; Mainta E; Valotassiou V; Souvatzoglou M; Sotiropoulou M; Nakopoulou L; Lazaris D; Louvrou A; Melissinou M; Tzannetaki A; Pirmettis I; Koutsikos J; Zerva C
    Breast Cancer Res; 2005; 7(1):R33-45. PubMed ID: 15642168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of Tc-99m-MIBI for breast carcinoma in correlation with mammography and sonography.
    Habib S; Maseeh-uz-Zaman ; Hameed A; Niaz K; Hashmi H; Kamal S
    J Coll Physicians Surg Pak; 2009 Oct; 19(10):622-6. PubMed ID: 19811712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
    Fuster D; Muñoz M; Pavia J; Palacín A; Bellet N; Mateos JJ; Martín F; Ortega M; Setoain FJ; Pons F
    Nucl Med Commun; 2002 Jan; 23(1):31-8. PubMed ID: 11748435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of primary tumor SUV
    Yoo J; Yoon HJ; Kim BS
    Ann Nucl Med; 2017 Jan; 31(1):19-28. PubMed ID: 27645144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrite (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions.
    Omar WS; Eissa S; Moustafa H; Farag H; Ezzat I; Abdel-Dayem HM
    Anticancer Res; 1997; 17(3B):1639-44. PubMed ID: 9179210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 99Tcm-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement.
    Schillaci O; Scopinaro F; Danieli R; Tavolaro R; Picardi V; Cannas P; Colella AC
    Nucl Med Commun; 1997 Sep; 18(9):839-45. PubMed ID: 9352550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Usefulness of quantification and visual analysis of the uptake of (99m)Tc-MIBI in the diagnosis of mammary lesions].
    Mulero F; Roca V; Nicolás F; Castellón I; Fuentes T; Abad L; Illana J; Nuño de la Rosa JA
    Rev Esp Med Nucl; 2000 Jun; 19(3):192-8. PubMed ID: 11062082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.